Skip to main content

KBC Group NV

Position in KRYS — Krystal Biotech, Inc.

CIK 1411133 Brussels, C9

Position in KRYS

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$254,593
+$77,644 QoQ
Shares Held
685
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#297
of 419 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in KRYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

KBC Group NV holds $308,329,109 across 107 Biotechnology names. KRYS ranks #31 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KRYS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $254,593 685
2026-03-31 $176,949 685
2025-12-31 $168,879 685
2025-09-30 $120,923 685
2025-06-30 $94,160 685
2025-03-31 $169,301 939
2024-12-31 $147,103 939
2024-09-30 $116,863 642
2024-06-30 $93,656 510
2024-03-31 $84,160 473
2023-12-31 $58,680 473
2023-09-30 $54,868 473
2021-09-30 $103,114 1,975
2021-06-30 $134,300 1,975
2021-03-31 $152,154 1,975
2020-12-31 $118,500 1,975
2020-09-30 $85,023 1,975
2020-06-30 $81,804 1,975
2020-03-31 $16,215 375